We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
S&P Futures
5,179.50 +12.00 (+0.23%) Dow Futures
38,317.00 +79.00 (+0.21%) Nasdaq Futures
18,225.25 +46.00 (+0.25%) Russell 2000 Futures
2,031.20 +11.40 (+0.56%) Crude Oil
85.71 +0.05 (+0.06%) Gold
2,372.00 -2.10 (-0.09%)
IDEXX Laboratories, Inc. (IDXX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 503.10 |
| Open | 497.50 |
| Bid | 497.41 x 100 |
| Ask | 498.04 x 100 |
| Day's Range | 492.99 - 501.44 |
| 52 Week Range | 372.50 - 583.39 |
| Volume | |
| Avg. Volume | 421,569 |
| Market Cap | 41.344B |
| Beta (5Y Monthly) | 1.26 |
| PE Ratio (TTM) | 49.48 |
| EPS (TTM) | 10.06 |
| Earnings Date | May 01, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 604.62 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for IDXX
Related Research
- IDEXX Laboratories, Inc.IDXX: Lowering target price to $546.00IDEXX LABORATORIES INC has an Investment Rating of HOLD; a target price of $546.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.RatingFair ValueEconomic Moat5 days agoArgus Research
ZacksIdexx Laboratories (IDXX) Beats Stock Market Upswing: What Investors Need to Know
Idexx Laboratories (IDXX) concluded the recent trading session at $519.81, signifying a +0.99% move from its prior day's close.
ZacksAll You Need to Know About Idexx (IDXX) Rating Upgrade to Buy
Idexx (IDXX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ZacksWill Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Business WireIDEXX Laboratories to Release 2024 First Quarter Financial Results
WESTBROOK, Maine, April 04, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
ZacksWant Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
ZacksHere's Why You Should Invest in IDEXX (IDXX) Stock Right Now
The strength of the CAG Diagnostics business buoys optimism for IDEXX (IDXX).
Insider MonkeyIDEXX Laboratories (IDXX) Gained 27% on Improved Operating Margins
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy underperformed the Russell Midcap Growth Index and returned 13.66% (gross) and 13.44% (net) while the index return was – 14.55%. In addition, please […]
Insider MonkeyStrong Fiscal Q3 Earnings Pushed IDEXX Laboratories (IDXX) in Q4
Fred Alger Management, an investment management company, released its “Alger Mid Cap Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. U.S. equities had a robust run in the fourth quarter, with the S&P Index finishing up 11.69%. The fund underperformed the Russell Midcap Growth Index in the quarter. […]
Simply Wall St.IDEXX Laboratories' (NASDAQ:IDXX) earnings growth rate lags the 19% CAGR delivered to shareholders
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...
- Simply Wall St.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
It is hard to get excited after looking at IDEXX Laboratories' (NASDAQ:IDXX) recent performance, when its stock has...
Morningstar Rating
Rating
Fair Value
Economic Moat
People Also Watch
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| ZTS Zoetis Inc. | |||
| DXCM DexCom, Inc. | |||
| ALGN Align Technology, Inc. | |||
| ZBRA Zebra Technologies Corporation | |||
| MASI Masimo Corporation |
Similar to IDXX
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| MTD Mettler-Toledo International Inc. | |||
| WAT Waters Corporation | |||
| TMO Thermo Fisher Scientific Inc. | |||
| MEDP Medpace Holdings, Inc. | |||
| DHR Danaher Corporation |
Analyst Price Targets (9)
Upgrades & Downgrades
| Maintains | JP Morgan: Overweight to Overweight | 2/6/2024 | |
| Maintains | Barclays: Overweight to Overweight | 2/6/2024 | |
| Downgrade | Piper Sandler: Overweight to Neutral | 1/30/2024 | |
| Maintains | Goldman Sachs: Buy to Buy | 1/17/2024 | |
| Maintains | Piper Sandler: Overweight to Overweight | 11/6/2023 | |
| Maintains | Goldman Sachs: Buy to Buy | 11/3/2023 |
Company Profile
One IDEXX Drive
Westbrook, ME 04092
United States
207 556 0300
https://www.idexx.com
Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 11,000
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
